The data management software provider has now secured a total of $115m, Cisco Investments returning to back its latest round.

UT Southwestern spinout Recode Therapeutics has completed an oversubscribed $80m series A round featuring Osage University Partners.

The Montana State University-backed edible protein developer has rebranded from Sustainable Bioproducts and received series B funding.

The edible protein developer has rebranded from Sustainable Bioproducts and received series B funding from investors including existing backers Danone and Archer Daniels Midland.

Lilly Asia Ventures, an investor in the cancer drug developer since its series A round, returned to back a series C that doubled its overall funding to $140m.

University of Wisconsin-Madison gene medicine developer Design Therapeutics has attracted SR One for its series A round.

SR One led a round disclosed by the genetic medicine developer, a spinout of University of Wisconsin-Madison, as it emerged from stealth.

Circle Pharma, a spinout of UCSF and UC Santa Cruz, has collected series B funding from investors including another UC campus, Berkeley.

Eli Lilly took part in an $80.3m round that pushed chronic illness drug developer Sigilon Therapeutics' overall funding to nearly $200m.

Strategic partner Lyell Immunopharma led a $45m round for Eureka Therapeutics, which will use the money to advance a pipeline that includes a treatment for liver cancer.